MedTrace Logo

Everolimus in Combination With Cyclosporine Microemulsion in de Novo Renal Transplant Recipients

NCT00170885 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2016-11-16

No results posted yet for this study

Summary

The purpose of the study in de novo renal transplant patients is to evaluate the effect on renal function of an optimized new regimen in comparison with the standard everolimus exposure plus a low-dose cyclosporine microemulsion regimen.

Conditions

  • Kidney Transplantation

Interventions

DRUG

Everolimus

Sponsors & Collaborators

Principal Investigators

  • Novartis · Novartis

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-05-31
Primary Completion
2007-07-31
Completion
2007-07-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00170885 on ClinicalTrials.gov